Treating all multidrug-resistant tuberculosis patients, not just bacteriologically confirmed cases.

India has responded to the epidemic of multidrug-resistant tuberculosis (MDR-TB) with a number of strategies

From:
Department for International Development
Published
1 June 2016
Country:
India
Document Type:
Journal Article
Theme:
Health
Authors:
Das, M, Isaakidis, P, Van den Bergh, R, Kumar, A.M.V., Sharath, B.N., Mansoor, H, Saranchuk, P

Abstract

The guidelines on notification1 and standards of care2 introduced by the Revised National Tuberculosis Control Programme (RNTCP) are important contributions towards the appropriate diagnosis and treatment of MDR-TB patients. However, these guidelines apply only to bacteriologically confirmed MDR-TB, while those patients without bacteriological confirmation are usually not treated.

This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)

Citation

M. Das, P. Isaakidis, R. Van den Bergh, A. M. V. Kumar, B. N. Sharath, H. Mansoor, P. Saranchuk (2016) Treating all multidrug-resistant tuberculosis patients, not just bacteriologically confirmed cases International Union Against Tuberculosis and Lung Disease Health Solutions for the Poor, vol 6 no 2, published 21 June 2016.

Treating all multidrug-resistant tuberculosis patients, not just bacteriologically confirmed cases Subscription or payment maybe required to access

Updates to this page

Published 1 June 2016
Contents